- Home
- LPTH vs DAWN Comparison
LPTH vs DAWN Comparison
Compare LPTH & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- DAWN
- Stock Information
- Founded
- LPTH 1985
- DAWN 2018
- Country
- LPTH United States
- DAWN United States
- Employees
- LPTH N/A
- DAWN N/A
- Industry
- LPTH Semiconductors
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- DAWN Health Care
- Exchange
- LPTH Nasdaq
- DAWN Nasdaq
- Market Cap
- LPTH 229.5M
- DAWN 624.8M
- IPO Year
- LPTH 1996
- DAWN 2021
- Fundamental
- Price
- LPTH $6.69
- DAWN $6.99
- Analyst Decision
- LPTH Strong Buy
- DAWN Strong Buy
- Analyst Count
- LPTH 3
- DAWN 7
- Target Price
- LPTH $5.33
- DAWN $27.86
- AVG Volume (30 Days)
- LPTH 1.7M
- DAWN 922.7K
- Earning Date
- LPTH 11-06-2025
- DAWN 10-29-2025
- Dividend Yield
- LPTH N/A
- DAWN N/A
- EPS Growth
- LPTH N/A
- DAWN N/A
- EPS
- LPTH N/A
- DAWN N/A
- Revenue
- LPTH $33,626,969.00
- DAWN $187,638,000.00
- Revenue This Year
- LPTH $19.59
- DAWN $12.56
- Revenue Next Year
- LPTH $47.43
- DAWN $48.02
- P/E Ratio
- LPTH N/A
- DAWN N/A
- Revenue Growth
- LPTH 2.59
- DAWN 2190.50
- 52 Week Low
- LPTH $1.15
- DAWN $5.64
- 52 Week High
- LPTH $6.97
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- LPTH 67.85
- DAWN 46.39
- Support Level
- LPTH $5.75
- DAWN $6.90
- Resistance Level
- LPTH $6.97
- DAWN $7.58
- Average True Range (ATR)
- LPTH 0.57
- DAWN 0.26
- MACD
- LPTH 0.09
- DAWN -0.07
- Stochastic Oscillator
- LPTH 87.61
- DAWN 10.78
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.